Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial

BACKGROUND: Recovery after a major stroke is usually limited, but cell therapy for patients with fixed neurologic deficits is emerging. Several recent clinical trials have investigated mesenchymal stem cell (MSC) therapy for patients with ischemic stroke. We previously reported the results of a cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Suk Jae, Moon, Gyeong Joon, Chang, Won Hyuk, Kim, Yun-Hee, Bang, Oh Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016561/
https://www.ncbi.nlm.nih.gov/pubmed/24083670
http://dx.doi.org/10.1186/1745-6215-14-317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016561/
https://www.ncbi.nlm.nih.gov/pubmed/24083670
http://dx.doi.org/10.1186/1745-6215-14-317

Ejemplares similares